AzTrials
AzTrials

Breastfeeding WomenMOMSNCT01971216

Mother-infant Signalling During Breastfeeding

A study testing Relaxation in people with Breastfeeding Women, run by University College, London at 1 site in Malaysia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Primary hypotheses 1. The use of a relaxation tape by breastfeeding mothers that will be given starting at week 2 postpartum, will result in : i) reduced maternal stress and anxiety ii) the production of a higher volume of breast milk iii) lower milk cortisol concentrations iv) favourable effects on infant behaviour… Read more about this study

Who is it for?
Ages 18 to 40 years, women onlyHealthy volunteers can take part
Conditions the study is for
Breastfeeding Women
What is being tested?
Relaxation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
64 participants
Where
1 siteMalaysia
Study dates
Dec 2013to Jan 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Primiparous mother with singleton pregnancy Infant is singleton and born at term (37-42 week of gestation) Infant birth weight of >2500 g (5,5 pounds or 5 pounds and 8,2 ounces) Mother and infant are generally healthy (free of serious illness that can affect breastfeeding or nursing infant, or energy balance of the infant).
  • No current or recent involvement in other research studies that could potentially affect any of outcome measures.
  • Mother speaks and understands either English only or English and Malay (some questionnaires are in English)

Who cannot join

  • Mother or baby has a major illness that affects nursing or breastfeeding, or affects energy balance of the infant.
  • Mother smokes Mothers who do not exclusively breastfeed their infant
  • -

Trial locations and contacts

1 site in 1 country.

Malaysia1 site
  • Faculty of Medicine and Health Science, Universiti Putra Malaysia (UPM).

    Kuala Lumpur

Other trials in Malaysia

About this study

Official title: Mother-infant Signalling During Breastfeeding: A Randomised Trial Investigating the Effects of a Relaxation Intervention in Breastfeeding Mothers on Breast Milk Production, Breast Milk Cortisol and Infant Behaviour and Growth.

Primary hypotheses

  1. The use of a relaxation tape by breastfeeding mothers that will be given starting at week 2 postpartum, will result in : i) reduced maternal stress and anxiety ii) the production of a higher volume of breast milk iii) lower milk cortisol concentrations iv) favourable effects on infant behaviour (less crying, more sleeping) v) higher milk intake by the infant vi) more optimal growth, specifically higher lean mass and lower fat mass (body composition)

Secondary hypotheses (i) Infant temperament/behaviour and gender influence milk and energy intake and hence early growth and body composition (ii) Non-nutrient factors in breast milk (hormones including ghrelin and leptin) influence infant behaviour and feeding patterns and hence infant growth and body composition.

Being tested
Relaxation
Keywords
Breastfeeding, relaxation, anxiety, infant growth
Medical subject headings
Breast Feeding, Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • RelaxationBehavioural

    Also called Relaxation tape - audio tape with visual imagery and relaxation exercises

Study groups in NCT01971216
Study groupRoleWhat they receive
ControlNo interventionBreastfeeding mothers who are not randomised to relaxation intervention
RelaxationExperimentalBreastfeeding mothers randomised to use relaxation tape at 2 weeks post-partum
Receives: Behavioral: Relaxation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Maternal stress and anxiety

    Maternal stress and anxiety assessed using the Cohen's Perceived Stress Scale (PSS) and Beck Anxiety Inventory (BAI) respectively (change in score from baseline to end-point at 12 weeks)

    Measured: Baselibne to 12 weeks

  2. Breast milk volume at 12 weeks assessed non-invasively using stable isotope techniques

    Breast milk volume at 12 weeks assessed non-invasively using stable isotope techniques

    Measured: 12 weeks

  3. Breast milk cortisol concentrations at 12 weeks

    Measured: 12 weeks

  4. Infant behaviour measured using a 3-day diary at 12 weeks

    Measured: 12 weeks

  5. Infant weight and body composition measured using stable isotopes at 12 weeks

    Measured: 12 weeks

  6. Physiological changes (maternal saliva cortisol, breast milk cortisol and milk volume) before and after physiological-mini test in intervention group at 2,6 and 12 weeks.

    Measured: 2,6,12 weeks

Secondary outcomes (2)
  1. Non-nutrient factors in breast milk - leptin and ghrelin

    Measured: 2,6,12 weeks

  2. Macronutrient composition of breast milk (fat and protein)

    Measured: 2,6,12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Oct 2013 (estimated)
  2. Study startDec 2013
  3. Primary completionMar 2015
  4. Study completionJan 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
64 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01971216
Sponsor's protocol ID
13NT05
Acronym
MOMS
Status last verified
Jul 2018
First submitted
23 Oct 2013
Last updated
12 Jul 2018
Results posted
No
Data monitoring committee
No

Publications

  • Mohd Shukri NH, Wells J, Eaton S, Mukhtar F, Petelin A, Jenko-Praznikar Z, Fewtrell M. Randomized controlled trial investigating the effects of a breastfeeding relaxation intervention on maternal psychological state, breast milk outcomes, and infant behavior and growth. Am J Clin Nutr. 2019 Jul 1;110(1):121-130. doi: 10.1093/ajcn/nqz033.

    PubMed 31161202
  • Shukri NHM, Wells J, Mukhtar F, Lee MHS, Fewtrell M. Study protocol: An investigation of mother-infant signalling during breastfeeding using a randomised trial to test the effectiveness of breastfeeding relaxation therapy on maternal psychological state, breast milk production and infant behaviour and growth. Int Breastfeed J. 2017 Jul 14;12:33. doi: 10.1186/s13006-017-0124-y. eCollection 2017.

    PubMed 28725257

Questions about this trial

What is this clinical trial studying?

A study testing Relaxation in people with Breastfeeding Women, run by University College, London at 1 site in Malaysia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Jul 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Malaysia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Maternal stress and anxiety (time frame: Baselibne to 12 weeks). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01971216, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jul 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in